Corning has announced that Actar AB, a part of the Karolinska Institutet innovations system, confirmed its ability to provide label-free drug screening services via the Corning Epic System.
Actar is the only company to provide high-throughput label-free drug screening to academic researchers in Scandanavia and Europe on a fee-for-service basis.
'The Corning Epic System makes us an even more powerful partner with academic institutions in developing drugs out of academic discoveries,' said Claes Post, chairman of the Actar AB board.
'Actar's decision to purchase the Corning Epic System highlights the significant potential of label-free technology in drug discovery,' said Ron Verkleeren, business director, Corning Epic System.
The Corning Epic System uses optical biosensor technology to measure a broad range of biological responses that are undetectable with conventional methods.
